NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. Read more about NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021. Read more about NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.
Targeting KRAS: Good, But Is It Good Enough? Read more about Targeting KRAS: Good, But Is It Good Enough?
Authors' Reply: To the Letter to the Editor by Groheux et al. Read more about Authors' Reply: To the Letter to the Editor by Groheux et al.
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. Read more about NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
Pan-Cancer Screening: A Dream or a Nightmare. Read more about Pan-Cancer Screening: A Dream or a Nightmare.
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Read more about Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.